Profil
Gudrun Bachmann currently works at Oculis Holding AG, as Chief Technology Officer from 2024.
Dr. Bachmann also formerly worked at Sandoz AG, as Head-Biopharmaceutical Development from 2012 to 2014, Fresenius Kabi Schweiz AG, as Global Head-CMC leads from 2020 to 2022, and Alvotech hf, as Head-Drug Product Biopharmaceutical Development from 2015 to 2018.
Dr. Bachmann received her graduate degree from the University of Aalborg and doctorate degree from Institute of Cancer Research Royal Marsden Hospital.
Aktiva positioner av Gudrun Bachmann
| Företag | Position | Start |
|---|---|---|
| OCULIS HOLDING AG | Teknisk/Vetenskaplig/F&U Direktör | 2024-09-01 |
Tidigare kända positioner av Gudrun Bachmann
| Företag | Position | Slut |
|---|---|---|
Fresenius Kabi Schweiz AG | Företagsledare/Principal | 2022-01-01 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Företagsledare/Principal | 2018-01-01 |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Företagsledare/Principal | 2014-01-01 |
Gudrun Bachmanns utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
University of Aalborg
University of Aalborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fresenius Kabi Schweiz AG | |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Institute of Cancer Research Royal Marsden Hospital
Institute of Cancer Research Royal Marsden Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oculis Holding AG
Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
















